Phacilitate Leaders Forum

Supply chain & Logistics for Advanced Therapies

Supply chain & Logistics for Advanced Therapies


The cell and gene therapy sectors are maturing with more and more products nearing the market, however the challenges of regulatory approval and creating a commercially viable product are far from being solved.

One of the main barriers to commercial viability is the supply chain, which contributes hugely to the overall cost of goods (COGs) and is limited by infrastructure, temperature requirements and, of course, the time frame for transportation vs. cell viability.

In this e-book we explore the impact of the supply chain on commercialisation and provide in depth insight and knowledge from the industry to prevent further failures and ensure the best levels of patient care can reach the market, including:

  • Designing a robust, flexible supply chain design
  • The impact of product formulation on storage needs and supply chain costs

Please complete the form below to view the ebook:


Form 'FB_F4A59634-5056-B731-4CCA6E24A04B1CFC' not found.


  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd